Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.
about
Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progressionErythropoietin blockade inhibits the induction of tumor angiogenesis and progression.The effect of erythropoietin on normal and neoplastic cells.Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma.A new mechanism for pillar formation during tumor-induced intussusceptive angiogenesis: inverse sproutingAlternative vascularization mechanisms in cancer: Pathology and therapeutic implications.Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusionRecombinant human erythropoietin alpha modulates the effects of radiotherapy on colorectal cancer microvessels.Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.Vaccinia virus-mediated expression of human erythropoietin in tumors enhances virotherapy and alleviates cancer-related anemia in mice.Erythropoietin and Its Angiogenic Activity.Erythropoietin receptor contributes to melanoma cell survival in vivo.Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method.
P2860
Q27320755-7BBC7C29-D831-4201-B97D-AD0AD14B9F43Q33288270-D7B8D668-07FA-4986-9190-79D18DC097CCQ34291437-F33CE9CF-01F6-4EAF-BB15-885F2012AB48Q35025478-ACF8243C-8EF9-4609-A208-2696BF0635A1Q35168262-3A444363-C226-4972-B990-A012744D40ABQ35570450-EA05C0A3-5D57-486D-90BC-BAC3C8CBA1C0Q35633372-04039C8B-1A35-45FE-88FC-1175DAD4A9F5Q36610013-885D2154-1520-466A-892D-626C5366A687Q37046655-A05B5098-B693-4484-8BF8-C06D02AC6AE6Q37694808-47E963AF-3F9B-431F-885C-E4C0F2F7269CQ39139854-ED225221-7D1E-4A39-921A-65F1D1E61E4AQ39432541-5358CC16-6423-41B9-B13E-942FD127B61AQ39486076-89CDA970-30AB-4A80-9D91-68D0FC28AC62Q42466000-DACB1619-824B-4E49-897E-73CE92D92DC2
P2860
Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Recombinant human erythropoiet ...... apy in human xenograft models.
@ast
Recombinant human erythropoiet ...... apy in human xenograft models.
@en
type
label
Recombinant human erythropoiet ...... apy in human xenograft models.
@ast
Recombinant human erythropoiet ...... apy in human xenograft models.
@en
prefLabel
Recombinant human erythropoiet ...... apy in human xenograft models.
@ast
Recombinant human erythropoiet ...... apy in human xenograft models.
@en
P2093
P921
P1433
P1476
Recombinant human erythropoiet ...... rapy in human xenograft models
@en
P2093
Agnes Vágó
Bíborka Bereczky
József Tímár
József Tóvári
Norbert Varga
Réka Gilly
Sándor Paku
P304
P356
10.1158/0008-5472.CAN-04-2498
P407
P577
2005-08-01T00:00:00Z